Ovid Therapeutics (OVID) Total Debt Growth (1y) (2020)
Powered by 
Analysis
Ovid Therapeutics (OVID) Total Debt Growth (1y) (2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -2.50% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -4.39% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 52.27% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 15.32% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 2.26% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 8.51% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 12.42% |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -17.14% |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 717.91% |
| Sep 30, 2020 | -53.91% |
| Jun 30, 2020 | -77.96% |
| Mar 31, 2020 | -77.78% |